Prolotherapy: An Advanced Therapy for Joint Inflammation, Weakness and Pain
What is Prolotherapy?
Prolotherapy, also known Joint Reconstruction Therapy, is a recognized orthopedic procedure that stimulates the body’s natural healing processes to strengthen joints weakened by traumatic or over-use injury. Traditional approaches with surgery and anti-inflammatory drugs often fail to stabilize the joints and relieve this pain permanently. Prolotherapy, with its unique ability to directly address the cause of instability, can repair the weakened sites and produce new tissues, resulting in permanent stabilization of the joint.
How does Prolotherapy work?
With a precise injection of a mild solution directly on the site of the torn or stretched ligament or tendon, prolotherapy stimulates of the body’s natural healing mechanisms to lay down new tissue on the wakened area. The response created by the injection encourages growth of new ligament or tendon fibers, resulting in a tightening of the weakened structure. Additional treatments repeat this process, allowing a gradual build up of tissue to restore the original strength to the area.
What areas of the body can be treated?
This form of therapy can be used to treat can treat any joint, ligament or tendon in the body. For example, it can treat knee pain, shoulder pain, jaw pain, carpal tunnel syndrome and disc problems at any level of the spine. The therapy affects only the area treated and does not cause any problem in any other area.
How often do I need these treatments?
The treatments should be administered every 2-4 weeks, as determined by your treating physician.
Who administers Prolotherapy?
Physicians who administer this form of therapy are trained by the American College of Osteopathic Pain Management & Sclerotherapy. Postgraduate training is a prerequisite before treating any patient with a medical orthopedic problem.
Dr. Carrie Mousseau, MD has completed this training multiple times, as well as at the University of Wisconsin School of Medicine and Public Health and the Hackett Hemwall Patterson Foundation. She has been treating with Prolotherapy since 2003.